AlHarbi, A.; Alshamrani, M.; Khan, M.; Alnatsheh, A.; Aseeri, M.
Real-World Experience of Monitoring Practice of Endocrinopathies Associated with the Use of Novel Targeted Therapies among Patients with Solid Tumors. Med. Sci. 2022, 10, 65.
https://doi.org/10.3390/medsci10040065
AMA Style
AlHarbi A, Alshamrani M, Khan M, Alnatsheh A, Aseeri M.
Real-World Experience of Monitoring Practice of Endocrinopathies Associated with the Use of Novel Targeted Therapies among Patients with Solid Tumors. Medical Sciences. 2022; 10(4):65.
https://doi.org/10.3390/medsci10040065
Chicago/Turabian Style
AlHarbi, Atika, Majed Alshamrani, Mansoor Khan, Abdelmajid Alnatsheh, and Mohammed Aseeri.
2022. "Real-World Experience of Monitoring Practice of Endocrinopathies Associated with the Use of Novel Targeted Therapies among Patients with Solid Tumors" Medical Sciences 10, no. 4: 65.
https://doi.org/10.3390/medsci10040065
APA Style
AlHarbi, A., Alshamrani, M., Khan, M., Alnatsheh, A., & Aseeri, M.
(2022). Real-World Experience of Monitoring Practice of Endocrinopathies Associated with the Use of Novel Targeted Therapies among Patients with Solid Tumors. Medical Sciences, 10(4), 65.
https://doi.org/10.3390/medsci10040065